Prism Medico and Pharmacy36.50
+2.34 (+6.85%)

Prism Medico and Pharmacy Share Price

36.50+2.34 (+6.85%)
+91.40% past 1 Year

Corporate filings & documents

Announcements

Dear Sir/Madam Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 05th November 2026) which commenced at 03:30 P.M. and concluded at 05:30 P.M. have inter alia approved the following:? The Board considered and approved the Unaudited Standalone Financial Results of the company for the quarter and half year ended 30th September 2026 alongwith the Limited Review Report duly signed by the Auditors of the company. You are requested to kindly take the same on record and oblige.
3 hours ago
Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 inter alia to consider and approve - Consider approve and take on record the Unaudited Standalone Financial Results of the company along with the Limited Review Report for the quarter ended 30th September 2026 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. - Consider and discuss any other routine matter or business of the company.
5 days ago
Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 inter alia to consider and approve - Consider approve and take on record the Unaudited Standalone Financial Results of the company along with the Limited Review Report for the quarter ended 30th September 2026 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. - Consider and discuss any other routine matter or business of the company.
5 days ago
Dear Sir/ Madam Pursuant to Regulation 46 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015 please find attached the intimation regarding the website of the company. The website address of the company is https://www.prismmedico.in. The website is updated and functional. You are requested to kindly take the same on record and oblige.Thanking you.
1 week ago
Dear Sir/ Madam Pursuant to Regulation 46 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015 please find attached the intimation regarding the website of the company. The website address of the company is https://www.prismmedico.in. The website is updated and functional. You are requested to kindly take the same on record and oblige.Thanking you.
1 week ago
Dear Sir/Madam Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 please find attached the confirmation certificate issues by RTA for the quarter ended 30th September 2026.You are requested to kindly take the same on record and oblige.Thanking you.
3 weeks ago
Dear Sir/Madam Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 please find attached the confirmation certificate issues by RTA for the quarter ended 30th September 2026.You are requested to kindly take the same on record and oblige.Thanking you.
3 weeks ago
Dear Sir/ MadamPursuant to Regulation 57(5) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (LODR) please find the attached Intimation for the quarter on 30th September 2026.You are requested to kindly take the same on record and oblige.Thanking you.
1 month ago
Dear Sir/ MadamPursuant to Regulation 57(5) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (LODR) please find the attached Intimation for the quarter on 30th September 2026.You are requested to kindly take the same on record and oblige.Thanking you.
1 month ago
Dear Sir/ Madam Pursuant to Regulation 57(4) of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015 (LODR) please find the attached intimation.You are requested to kindly take the same on record and oblige. Thanking you.
1 month ago
Dear Sir/ Madam Pursuant to Regulation 57(4) of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015 (LODR) please find the attached intimation.You are requested to kindly take the same on record and oblige. Thanking you.
1 month ago
Dear Sir/Madam Pursuant to Code of Conduct to regulate Monitor and report Trading by Insiders (Code) and applicable SEBI Regulations please find the attached intimation by the company for the quarter and half year ended on 30th September 2026.You are requested to kindly take the same on record and oblige.Thanking you.
1 month ago
Dear Sir/Madam Pursuant to Code of Conduct to regulate Monitor and report Trading by Insiders (Code) and applicable SEBI Regulations please find the attached intimation by the company for the quarter and half year ended on 30th September 2026.You are requested to kindly take the same on record and oblige.Thanking you.
1 month ago
Dear Sir/ Madam Pursuant to Provisions of Section 108 of the Companies Act 2013 read with Rule 20 of the Companies (Management and Administration) Rules 2014 and provisions of Regulation 44 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith Scrutinizers Report on remote e-voting and e-voting at the 24th Annual General Meeting of the Company held on 19th September 2026.You are requested to take the same on record and oblige.Thanking You.
1 month ago
Dear Sir/ Madam Pursuant to Provisions of Section 108 of the Companies Act 2013 read with Rule 20 of the Companies (Management and Administration) Rules 2014 and provisions of Regulation 44 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith Scrutinizers Report on remote e-voting and e-voting at the 24th Annual General Meeting of the Company held on 19th September 2026.You are requested to take the same on record and oblige.Thanking You.
1 month ago
Dear Sir/Madam Pursuant to Regulation 30(2) of SEBI (LODR) Regulations 2015 please find the attached proceedings of the 24th Annual General Meeting of the members of the company held on Saturday the 19th day of September 2026 at 12:30 P.M. through Video Conferencing/Other Audio Visual Means. You are requested to take the same on record and oblige. Thanking You.
1 month ago
Dear Sir/Madam Pursuant to Regulation 30(2) of SEBI (LODR) Regulations 2015 please find the attached proceedings of the 24th Annual General Meeting of the members of the company held on Saturday the 19th day of September 2026 at 12:30 P.M. through Video Conferencing/Other Audio Visual Means. You are requested to take the same on record and oblige. Thanking You.
1 month ago
Dear Sir/Madam The stock exchanges are informed that the 24th Annual General Meeting of the members of the company was held on Saturday the 19th day of September 2026 at 12:30 P.M. through Video Conferencing/Other Audio-Visual means. The outcome of the meeting is attached herewith.You are requested to take the same on record and oblige.Thanking You.
1 month ago
Dear Sir/Madam The stock exchanges are informed that the 24th Annual General Meeting of the members of the company was held on Saturday the 19th day of September 2026 at 12:30 P.M. through Video Conferencing/Other Audio-Visual means. The outcome of the meeting is attached herewith.You are requested to take the same on record and oblige.Thanking You.
1 month ago
Dear Sir/Madam Pursuant to Regulation 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith Annual Report of the company for the Financial Year 2025-2026. You are requested to kindly take the same on record and oblige.Thanking You.
2 months ago
Dear Sir/Madam Pursuant to Regulation 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed herewith Annual Report of the company for the Financial Year 2025-2026. You are requested to kindly take the same on record and oblige.Thanking You.
2 months ago
Dear Sir/ Madam Please find attached herewith intimation of Record Date for the purpose of conducting the 24th Annual General Meeting of the company to be held for the financial year ended 31st March 2026. You are requested to take the same on record and oblige.Thanking you.
2 months ago
Dear Sir/ Madam Please find attached herewith intimation of Record Date for the purpose of conducting the 24th Annual General Meeting of the company to be held for the financial year ended 31st March 2026. You are requested to take the same on record and oblige.Thanking you.
2 months ago
Dear Sir/Madam Please find the attached intimation of book closure for the 24th Annual General Meeting to be held for the financial year ended 31st March 2026.You are requested to take the same on record and oblige.Thanking you.
2 months ago
Dear Sir/Madam Please find the attached intimation of book closure for the 24th Annual General Meeting to be held for the financial year ended 31st March 2026.You are requested to take the same on record and oblige.Thanking you.
2 months ago
Dear Sir/ Madam Pursuant to Regulation 34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find attached herewith the Annual Report of the company for the financial year ended on March 31 2026.You are required to kindly take the same on record and oblige.Thanking you.
2 months ago
Dear Sir/ Madam Pursuant to Regulation 34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find attached herewith the Annual Report of the company for the financial year ended on March 31 2026.You are required to kindly take the same on record and oblige.Thanking you.
2 months ago
Dear Sir/ Madam Pursuant to Regulation 34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find attached herewith the Annual Report of the company for the financial year ended on March 31 2026.You are required to kindly take the same on record and oblige.Thanking you.
2 months ago
Dear Sir/ Madam Pursuant to Regulation 34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find attached herewith the Annual Report of the company for the financial year ended on March 31 2026.You are required to kindly take the same on record and oblige.Thanking you.
2 months ago
Dear Sir/Madam The 24th Annual General Meeting of M/s. Prism Medico and Pharmacy is scheduled to be held on 19th September 2026 through VC/OAVM. The notice of the same is attached herewith.You are requested to kindly take the same on record and oblige.Thanking you.
2 months ago
Dear Sir/Madam The 24th Annual General Meeting of M/s. Prism Medico and Pharmacy is scheduled to be held on 19th September 2026 through VC/OAVM. The notice of the same is attached herewith.You are requested to kindly take the same on record and oblige.Thanking you.
2 months ago
1. Considered & approved: (i) Directors Report for the F.Y. ended March 31 2026(ii) notice of 24th AGM to be held on September 19 2026 at 12:30 P.M. through VC/OAVM2. Fixed date for closure of Register of Members & Share Transfer Books from September 13 2026 to September 19 2026 for the purpose of AGM3. Fixed September 12 2026 as the cut-off date to record the entitlement of the shareholders to cast their votes electronically for the AGM4. Approved appointment of Mr. Mast Ram Chechi as scrutinizer to conduct e-voting process of AGM5. Considered & recommended: (i) re-appointment of M/s. Garg Mendiratta and Associates Chartered Accountants as the Statutory Auditors of the company(ii) appointment of M/s. SDK & Associates Practicing Company Secretaries as the Secretarial Auditors of the Company(iii) to invest the funds of the company(iv) variation in objects of the Preferential Issue & in utilisation of the proceeds thereof as approved in the EOGM held on March 20 2026
2 months ago
1. Considered & approved: (i) Directors Report for the F.Y. ended March 31 2026(ii) notice of 24th AGM to be held on September 19 2026 at 12:30 P.M. through VC/OAVM2. Fixed date for closure of Register of Members & Share Transfer Books from September 13 2026 to September 19 2026 for the purpose of AGM3. Fixed September 12 2026 as the cut-off date to record the entitlement of the shareholders to cast their votes electronically for the AGM4. Approved appointment of Mr. Mast Ram Chechi as scrutinizer to conduct e-voting process of AGM5. Considered & recommended: (i) re-appointment of M/s. Garg Mendiratta and Associates Chartered Accountants as the Statutory Auditors of the company(ii) appointment of M/s. SDK & Associates Practicing Company Secretaries as the Secretarial Auditors of the Company(iii) to invest the funds of the company(iv) variation in objects of the Preferential Issue & in utilisation of the proceeds thereof as approved in the EOGM held on March 20 2026
2 months ago
Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/08/2026 inter alia to consider and approve ? To consider and approve the Directors Report along with all necessary annexures thereof for the Financial Year ended March 31 2026;? To consider and fix day date time for holding the 24th Annual General Meeting of the company and approve the notice of the same;? To consider and fix the date for closure of Register of Members and Share Transfer Books for the purpose of Annual General Meeting;? To appoint scrutinizer to conduct e-voting and poll process of 24th Annual General Meeting of the company;? To consider and recommend the re-appointment of M/s. Garg Mendiratta and Associates Chartered Accountants as the statutory auditors of the company and fix their remuneration. ? To consider and recommend appointment of M/s. SDK & Associates Practicing Company Secretaries as the secretarial auditors of the Company for five financial years from FY 2026-2027 to FY 2030-2031.? To consider and discuss any other routine matter or business of the company.
2 months ago
Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/08/2026 inter alia to consider and approve ? To consider and approve the Directors Report along with all necessary annexures thereof for the Financial Year ended March 31 2026;? To consider and fix day date time for holding the 24th Annual General Meeting of the company and approve the notice of the same;? To consider and fix the date for closure of Register of Members and Share Transfer Books for the purpose of Annual General Meeting;? To appoint scrutinizer to conduct e-voting and poll process of 24th Annual General Meeting of the company;? To consider and recommend the re-appointment of M/s. Garg Mendiratta and Associates Chartered Accountants as the statutory auditors of the company and fix their remuneration. ? To consider and recommend appointment of M/s. SDK & Associates Practicing Company Secretaries as the secretarial auditors of the Company for five financial years from FY 2026-2027 to FY 2030-2031.? To consider and discuss any other routine matter or business of the company.
2 months ago
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 12th August 2026) which commenced at 01:30 P.M. and concluded at 03:30 P.M. have inter alia approved the following:? The Board considered and approved the Unaudited Standalone Financial Results of the company for the quarter ended 30th June 2026 alongwith the Limited Review Report duly signed by the Auditors of the company. You are requested to kindly take the same on record and oblige.
2 months ago
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 12th August 2026) which commenced at 01:30 P.M. and concluded at 03:30 P.M. have inter alia approved the following:? The Board considered and approved the Unaudited Standalone Financial Results of the company for the quarter ended 30th June 2026 alongwith the Limited Review Report duly signed by the Auditors of the company. You are requested to kindly take the same on record and oblige.
2 months ago
Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Unaudited Standalone Financial Results of the company along with the Limited Review Report for the quarter ended 30th June 2026 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
3 months ago
Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Unaudited Standalone Financial Results of the company along with the Limited Review Report for the quarter ended 30th June 2026 as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
3 months ago
Dear Sir/Madam This is to inform you that the website of M/s. Prism Medico and Pharmacy Limited is updated and functional as per Regulation 46 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015. The website of the company is http://www.prismmedico.in.You are requested to kindly take the same on record and oblige.Thank you.
3 months ago
Dear Sir/Madam This is to inform you that the website of M/s. Prism Medico and Pharmacy Limited is updated and functional as per Regulation 46 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015. The website of the company is http://www.prismmedico.in.You are requested to kindly take the same on record and oblige.Thank you.
3 months ago
Dear Sir/Madam Please find the attache statements of investor complaints for the quarter ended 30th June 2026. You are requested to kindly take the same on record and oblige. Thanking You.
3 months ago
Dear Sir/Madam Please find the attache statements of investor complaints for the quarter ended 30th June 2026. You are requested to kindly take the same on record and oblige. Thanking You.
3 months ago
Dear Sir/ Madam Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 please find the attached certificate issued by Registrar and Share Transfer Agent (RTA) for the quarter ended on 30th June 2026. Kindly take the same on record and oblige.Thank you.
3 months ago
Dear Sir/ Madam Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations 2018 please find the attached certificate issued by Registrar and Share Transfer Agent (RTA) for the quarter ended on 30th June 2026. Kindly take the same on record and oblige.Thank you.
3 months ago
Dear Sir/Madam Pursuant to Regulation 57(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find the attached intimation for your reference and record.Thanking you.
4 months ago
Dear Sir/Madam Pursuant to Regulation 57(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find the attached intimation for your reference and record.Thanking you.
4 months ago
Pursuant to Regulation 57(4) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (LODR) please find the attached intimation letter.You are requested to Kindly take the same on record and oblige.
4 months ago
Pursuant to Regulation 57(4) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (LODR) please find the attached intimation letter.You are requested to Kindly take the same on record and oblige.
4 months ago
Pursuant to Code of Conduct to regulate monitor and report trading by insiders (Code) and applicable SEBI Regulations please find the attached intimation letter that the trading window for dealing in securities of the company by insiders stands closed from July 1 2026 and will be re-opened 48 hours after the declaration of the financial results for the quarter ended June 30 2026. You are requested to kindly take the same on record and oblige.
4 months ago

Concalls & investor presentations

Empty box

No presentations found

Prism Medico and Pharmacy Ltd Share Price Today

The Prism Medico and Pharmacy Ltd share price today is ₹29. During the trading session, the Prism Medico and Pharmacy Ltd share price opened at ₹29.8 and recorded an intraday high of ₹29.8 and a low of ₹28.02. Last closing price was ₹28.94. Over the past 52 weeks, the Prism Medico and Pharmacy Ltd share price has ranged between ₹15.51 and ₹34.49. The current Prism Medico and Pharmacy Ltd stock price reflects real-time market activity based on executed trades on the exchange.